Valliant, John Fitzmaurice

Insider profile

Valliant, John Fitzmaurice's trades of Fusion Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
472.96
Quantity 65,156 +10.1%
Value US$2,468,224
Transaction date
Planned sale
Price
82.62
Quantity 44,887 -35.5%
Value US$4,041,291
Transaction date
Planned sale
Price
136.49
Quantity 94,704 -41.3%
Value US$2,866,816
Transaction date
Planned sale
Price
6.01
Quantity 922 -0.3%
Value US$5,541
Transaction date
Planned sale
Price
6.02
Quantity 367 -0.1%
Value US$2,209
Transaction date
Planned sale
Price
6.41
Quantity 11,994 -3.5%
Value US$76,882
Transaction date
Planned sale
Price
7.10
Quantity 18,255 -5.1%
Value US$129,610
Transaction date
Planned sale
Price
7.37
Quantity 2,600 -0.7%
Value US$19,162
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-04-29 2022-04-27
PlS Planned sale
65,156 +10.1%
472.96
US$2,468,224 		65,156 +10.1% 472.96 US$2,468,224
2022-04-26 2022-04-26
PlS Planned sale
44,887 -35.5%
82.62
US$4,041,291 		44,887 -35.5% 82.62 US$4,041,291
2022-04-26 2022-04-25
PlS Planned sale
94,704 -41.3%
136.49
US$2,866,816 		94,704 -41.3% 136.49 US$2,866,816
2022-04-21 2022-04-21
PlS Planned sale
922 -0.3%
6.01
US$5,541 		922 -0.3% 6.01 US$5,541
2022-04-21 2022-04-20
PlS Planned sale
367 -0.1%
6.02
US$2,209 		367 -0.1% 6.02 US$2,209
2022-04-18 2022-04-13
PlS Planned sale
11,994 -3.5%
6.41
US$76,882 		11,994 -3.5% 6.41 US$76,882
2022-04-13 2022-04-12
PlS Planned sale
18,255 -5.1%
7.10
US$129,610 		18,255 -5.1% 7.10 US$129,610
2022-04-13 2022-04-11
PlS Planned sale
2,600 -0.7%
7.37
US$19,162 		2,600 -0.7% 7.37 US$19,162